A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
CRISPR Therapeutics
Incyte Corporation
Incyte Corporation
University Hospital, Antwerp
Masonic Cancer Center, University of Minnesota
University of Florida
Xencor, Inc.
Incyte Corporation
Calithera Biosciences, Inc
Incyte Corporation
Incyte Corporation
Memorial Sloan Kettering Cancer Center
Emory University
Abramson Cancer Center at Penn Medicine
Emory University
Swiss Cancer Institute
Kantonsspital Winterthur KSW
Stanford University
Novartis
Stanford University
Children's Oncology Group
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)